By William Sumner, Hemp Business Journal Contributor
Last month, rumors emerged that Walmart’s Canada division was conducting preliminary investigations into stocking its stores with CBD products, a move many consider to be inspired by Canada’s legalizing adult-use cannabis sales.
The world’s first cannabidiol (CBD) based drug approved by the U.S. Food and Drug Administration (FDA) has finally hit the markets. On November 1, 2018, GW Pharmaceuticals (NASDAQ: GWPH) announced that its flagship drug, Epidiolex, is now available in all 50 U.S. states. Read More
Could cannabidiol (CBD) help treat patients suffering from brain tumors? According to a study released earlier this month, the answer is “Maybe." Read More
Licensing applications to grow hemp in the state of Wisconsin for the 2019 season are now available. Despite a lackluster harvest this year, due largely to a rain-filled Spring, state officials remain optimistic for the upcoming season. Read More
Just Published Asian-Pacific Hemp Brief
This report covers:
Key developments shaping the hemp and CBD market in China and the Asia Pacific
Quantitative demand estimates for the size of the total addressable hemp and CBD market in China
An examination of the potential pitfalls and hurdles that could slow growth of the legal industry in the near term.
Recommendations for investors and operators currently looking to capitalize on the opportunity in the APAC region.